首页 | 本学科首页   官方微博 | 高级检索  
     


A quick and efficient method to generate mammalian stable cell lines based on a novel inducible alphavirus DNA/RNA layered system
Authors:Alejandro Aranda  Jaione Bezunartea  Erkuden Casales  Juan R. Rodriguez-Madoz  Esther Larrea  Jesus Prieto  Cristian Smerdou
Affiliation:1. 3P Biopharmaceuticals S.L., Polígono Mocholí, C/Mocholí 2, 31110, Noain, Spain
2. Division of Hepatology and Gene Therapy, Center for Applied Medical Research, University of Navarra, Pamplona, Navarra, Spain
3. UFR des Sciences de la Santé Simone Veil, 2 Avenue de la Source de la Bievre, 78180, Montigny-Le-Bretonneux, France
4. Liver Unit, Clinica Universitaria de Navarra, CIBER-EHD, Pamplona, Spain
Abstract:We report a new method to generate high-expressing mammalian cell lines in a quick and efficient way. For that purpose, we developed a master cell line (MCL) containing an inducible alphavirus vector expressing GFP integrated into the genome. In the MCL, recombinant RNA levels increased >4,600-fold after induction, due to a doxycycline-dependent RNA amplification loop. The MCL maintained inducibility and expression during 50 passages, being more efficient for protein expression than a conventional cell line. To generate new cell lines, mutant LoxP sites were inserted into the MCL, allowing transgene and selection gene exchange by Cre-directed recombination, leading to quick generation of inducible cell lines expressing proteins of therapeutic interest, like human cardiotrophin-1 and oncostatin-M at several mg/l/24 h. These proteins contained posttranslational modifications, showed bioactivity, and were efficiently purified. Remarkably, this system allowed production of toxic proteins, like oncostatin-M, since cells able to express it could be grown to the desired amount before induction. These cell lines were easily adapted to growth in suspension, making this methodology very attractive for therapeutic protein production.
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号